These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37509294)

  • 1. Comparative Analysis of Photon Stereotactic Radiotherapy and Carbon-Ion Radiotherapy for Elderly Patients with Stage I Non-Small-Cell Lung Cancer: A Multicenter Retrospective Study.
    Aoki S; Onishi H; Karube M; Yamamoto N; Yamashita H; Shioyama Y; Matsumoto Y; Matsuo Y; Miyakawa A; Matsushita H; Ishikawa H
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Oncologic Outcomes between Carbon Ion Radiotherapy and Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
    Miyasaka Y; Komatsu S; Abe T; Kubo N; Okano N; Shibuya K; Shirai K; Kawamura H; Saitoh JI; Ebara T; Ohno T
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33419147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG).
    Okano N; Suefuji H; Nakajima M; Tokumaru S; Kubo N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
    J Radiat Res; 2023 Jun; 64(Supplement_1):i2-i7. PubMed ID: 37036751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for Operable Stage I NSCLC: A Japanese National Registry Study (J-CROS-LUNG).
    Kubo N; Suefuji H; Nakajima M; Tokumaru S; Okano N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shimizu K; Shioyama Y
    J Thorac Oncol; 2024 Mar; 19(3):491-499. PubMed ID: 37924974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of carbon-ion radiotherapy versus stereotactic body radiotherapy for non-small-cell lung cancer.
    Okazaki S; Shibuya K; Takura T; Miyasaka Y; Kawamura H; Ohno T
    Cancer Sci; 2022 Feb; 113(2):674-683. PubMed ID: 34820994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG).
    Kubo N; Suefuji H; Nakajima M; Tokumaru S; Okano N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
    Radiother Oncol; 2023 Jun; 183():109640. PubMed ID: 36990390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study.
    Watanabe K; Katsui K; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
    Radiat Oncol; 2021 Feb; 16(1):39. PubMed ID: 33622369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of carbon-ion radiotherapy for early stage non-small cell lung cancer.
    Ruan H; Xiong J
    Clin Transl Radiat Oncol; 2022 Sep; 36():16-23. PubMed ID: 35756194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
    Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
    J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly.
    Wang P; Zhang D; Guo XG; Li XM; Du LH; Sun BJ; Fang XQ; Guo YH; Guo J; An L; Qu GP; Liu CT
    Medicine (Baltimore); 2016 Dec; 95(52):e5723. PubMed ID: 28033277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of carbon-ion radiotherapy for locally advanced non-small-cell lung cancer.
    Hayashi K; Yamamoto N; Nakajima M; Nomoto A; Tsuji H; Ogawa K; Kamada T
    Cancer Sci; 2019 Feb; 110(2):734-741. PubMed ID: 30467928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution.
    Doupnik NP; Hirmiz K; Hussein AA; Agapito J; Pan M
    Cureus; 2022 Feb; 14(2):e21878. PubMed ID: 35273848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.
    Dong B; Wang J; Zhu X; Chen Y; Xu Y; Shao K; Zheng L; Ying H; Chen M; Cao J
    Radiat Oncol; 2019 Nov; 14(1):195. PubMed ID: 31699115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of stereotactic radiotherapy on elderly patients with stage I-II central non-small cell lung cancer.
    Ji X; Zhou B; Huang H; Wang Y; Jiang W; Wang J; Ding W; Wang Z; Chen G; Sun X
    Front Oncol; 2024; 14():1235630. PubMed ID: 38803531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size ≤ 5 cm: a propensity score matching analysis.
    Dong B; Zhu X; Jin J; Chen Y; Ying H; Chen Y; Lu F; Shen W; Wang J; Chen M
    J Thorac Dis; 2020 Oct; 12(10):5934-5954. PubMed ID: 33209426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial.
    Hoegen-Saßmannshausen P; Naumann P; Hoffmeister-Wittmann P; Ben Harrabi S; Seidensaal K; Weykamp F; Mielke T; Ellerbrock M; Habermehl D; Springfeld C; Dill MT; Longerich T; Schirmacher P; Mehrabi A; Chang DH; Hörner-Rieber J; Jäkel O; Haberer T; Combs SE; Debus J; Herfarth K; Liermann J
    JHEP Rep; 2024 Jun; 6(6):101063. PubMed ID: 38737600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥80years old): Extremely safe and effective.
    Kreinbrink P; Blumenfeld P; Tolekidis G; Sen N; Sher D; Marwaha G
    J Geriatr Oncol; 2017 Sep; 8(5):351-355. PubMed ID: 28739159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon-ion radiotherapy for octogenarians with locally advanced non-small-cell lung cancer.
    Hayashi K; Yamamoto N; Nakajima M; Nomoto A; Ishikawa H; Ogawa K; Tsuji H
    Jpn J Radiol; 2021 Jul; 39(7):703-709. PubMed ID: 33608792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.